Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | KRYS | KYMR | ||
| Company | Cytokinetics | Krystal Biotech Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 86.16 | 375.00 | 119.52 | ||
| High | 86.45 | 375.00 | 120.29 | ||
| Low | 83.59 | 355.55 | 114.00 | ||
| Latest | 84.86 | 365.81 | 119.35 | ||
| Change | -1.21 | -5.43 | +0.35 | ||
| % Change | -1.41% | -1.46% | +0.29% | ||
| Volume | 1,759,774 | 363,512 | 665,427 | ||
| 20-Day Average Volume | 2,606,574 | 392,366 | 1,322,831 | ||
| Previous Close | 86.07 | 371.24 | 119.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 80.87 | 354.65 | 104.14 | ||
| 20-Day Raw Stochastic | 83.46% | 76.20% | 79.52% | ||
| 20-Day Relative Strength | 62.44 | 63.80 | 69.22 | ||
| Weighted Alpha | +83.68 | +149.15 | +150.46 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 64% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.88% since 07/02/26 | -2.47% since 07/02/26 | +5.14% since 07/02/26 | ||
| Low | 82.20 on 07/08/26 | 355.55 on 07/10/26 | 111.21 on 07/06/26 | ||
| High | 87.93 on 07/07/26 | 382.13 on 07/09/26 | 120.90 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | +26.52% since 06/10/26 | +17.09% since 06/10/26 | +52.56% since 06/10/26 | ||
| Low | 67.45 on 06/11/26 | 312.25 on 06/11/26 | 77.79 on 06/11/26 | ||
| High | 88.31 on 06/30/26 | 382.54 on 06/30/26 | 130.05 on 06/25/26 | ||
| 3-Month | |||||
| %Chg | +30.53% since 04/10/26 | +41.24% since 04/10/26 | +40.33% since 04/10/26 | ||
| Low | 58.65 on 04/29/26 | 251.97 on 05/04/26 | 69.48 on 06/03/26 | ||
| High | 88.31 on 06/30/26 | 382.54 on 06/30/26 | 130.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +35.75% since 01/09/26 | +39.94% since 01/09/26 | +59.62% since 01/09/26 | ||
| Low | 58.43 on 03/13/26 | 242.00 on 03/31/26 | 66.21 on 01/20/26 | ||
| High | 88.31 on 06/30/26 | 382.54 on 06/30/26 | 130.05 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,709,948 | 10,944,151 | 9,788,702 | ||
| Shares Outstanding, K | 124,433 | 29,480 | 82,258 | ||
| Annual Sales | 88,040,000 | 389,130,000 | 39,210,000 | ||
| Annual Net Income | -784,960,000 | 204,830,000 | -311,350,000 | ||
| Last Quarter Sales | 19,360,000 | 116,360,000 | 34,370,000 | ||
| Last Quarter Net Income | -206,030,000 | 55,930,000 | -69,230,000 | ||
| 60-Month Beta | 0.42 | 0.50 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.67 on 05/05/26 | 1.83 on 05/04/26 | -0.71 on 04/30/26 | ||
| Earnings Date | 08/06/26 | 08/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 50.19 | 0.00 | ||